Pro-Dex Inc (PDEX)
46.75
+4.42
(+10.44%)
USD |
NASDAQ |
Nov 22, 16:00
46.78
+0.03
(+0.06%)
After-Hours: 20:00
Pro-Dex Cash from Financing (Quarterly): -1.006M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -1.006M |
| June 30, 2024 | -1.501M |
| March 31, 2024 | -2.03M |
| December 31, 2023 | 0.558M |
| September 30, 2023 | -1.298M |
| June 30, 2023 | 0.373M |
| March 31, 2023 | -0.497M |
| December 31, 2022 | -1.513M |
| September 30, 2022 | -0.853M |
| June 30, 2022 | 0.966M |
| March 31, 2022 | -0.498M |
| December 31, 2021 | -0.887M |
| September 30, 2021 | -0.371M |
| June 30, 2021 | -1.543M |
| March 31, 2021 | -0.089M |
| December 31, 2020 | 5.076M |
| September 30, 2020 | -0.356M |
| June 30, 2020 | -0.57M |
| March 31, 2020 | -0.895M |
| December 31, 2019 | -1.689M |
| September 30, 2019 | -0.825M |
| June 30, 2019 | -1.47M |
| March 31, 2019 | -0.262M |
| December 31, 2018 | -1.602M |
| September 30, 2018 | 3.784M |
| Date | Value |
|---|---|
| June 30, 2018 | -0.21M |
| March 31, 2018 | -0.037M |
| December 31, 2017 | 0.078M |
| September 30, 2017 | 2.171M |
| June 30, 2017 | 0.034M |
| March 31, 2017 | -0.151M |
| December 31, 2016 | -0.126M |
| September 30, 2016 | -0.055M |
| June 30, 2016 | -0.457M |
| March 31, 2016 | -0.501M |
| December 31, 2015 | 0.006M |
| September 30, 2015 | 0.495M |
| June 30, 2015 | -0.008M |
| March 31, 2015 | -0.094M |
| December 31, 2014 | -0.096M |
| September 30, 2014 | -0.005M |
| June 30, 2014 | 1.512M |
| March 31, 2014 | 0.004M |
| December 31, 2013 | -0.002M |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.015M |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.05M |
| September 30, 2012 | -0.774M |
| June 30, 2012 | -0.095M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-2.03M
Minimum
Mar 2024
5.076M
Maximum
Dec 2020
-0.4311M
Average
-0.7115M
Median
Cash from Financing (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 0.628M |
| Retractable Technologies Inc | -0.1343M |
| InfuSystems Holdings Inc | -6.752M |
| Xtant Medical Holdings Inc | 5.314M |
| Catheter Precision Inc | 4.02M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 1.887M |
| Cash from Investing (Quarterly) | -0.431M |
| Free Cash Flow | 6.406M |
| Free Cash Flow Per Share (Quarterly) | 0.4423 |
| Free Cash Flow to Equity (Quarterly) | -0.118M |
| Free Cash Flow to Firm (Quarterly) | 1.550M |
| Free Cash Flow Yield | 3.94% |